‘The Answer Is Greed’: Michael Burry Takes On Cathie Wood, Again
Well-known for making big bets on the market, former hedge fund manager Michael Burry shared a take on Ark Invest CEO Cathie Wood, someone he has battled with before.
Rocket Companies Makes Executive Leadership Changes: What Investors Need To Know
Fintech platform company Rocket Companies Inc. (NYSE: RKT) announced Monday two major leadership changes, including the retirement of CFO Julie Booth.
5 Things You Might Not Know About Bill Gates: Did He Really Start His First Company At Age 15?
Bill Gates is well-known as the co-founder of Microsoft Corporation (NASDAQ: MSFT). The entrepreneur is also a huge philanthropist creating the Bill and Melinda Gates Foundation in 2000 to help spread technology and medical advancements around the world and reduce poverty.
TerrAscend & Other Marijuana Players Just Made Some Key Exec Changes You Should Know About
TerrAscend Names New President Of Northeast Region
TerrAscend Corp. (OTCQX: TRSSF) has tapped Karim Bouaziz to serve as president of the Northeast region.
Former Crime Analyst To Lead Michigan Cannabis Agency & Latest Key Executive Changes In Marijuana Space
Former Crime Analyst To Lead Michigan Cannabis Agency
Eloxx Shares Plummet As Mid-Stage Cystic Fibrosis Study Results Miss Efficacy Endpoints
Eloxx Pharmaceuticals (NASDAQ: ELOX) announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation.
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to GENFIT’s (NASDAQ: GNFT) drug candidate GNS5611 (ezurpimtrostat) for the treatment of cholangiocarcinoma.
Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System
Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System.
Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.
BioLineRx Seeks FDA Nod For Stem Cell Mobilization Candidate
BioLineRx (NASDAQ: BLRX) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate Motixafortide in stem cell mobilization (SCM) for autologous bone marrow transplantation for multiple myeloma patients.
Kanye West’s Feud With Adidas And Gap Heats Up: What’s On The Line For Him And The Companies
In 2016, Kanye West's apparel brand Yeezy partnered with Adidas AG - ADR (OTCQX: ADDYY) for Adidas + Kanye West to manufacture footwear, apparel and accessories.